Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse, Special Emphasis Panel, Tools to Promote Security and Appropriate Prescribing of Scheduled Prescription Drugs (5560).
Date: January 5, 2010.
Time: 9 a.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: Sofitel Washington DC, Lafayette Sq, 806 15th Street NW., Washington, DC 20005.
Contact Person: Jose F. Ruiz, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 6101 Executive Blvd., Rm. 213, MSC 8401, Bethesda, MD 20892, 301-451-3086, firstname.lastname@example.org.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)Start Signature
Dated: December 14, 2009.
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-30110 Filed 12-18-09; 8:45 am]
BILLING CODE 4140-01-M